Back to Search Results

Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis

Department of Health Economics, Novo Nordisk A/S, Denmark. iodeyemi@aol.com

Current Medical Research and Opinion. 2009;25((1):):239-50.

Full text from:

Study details

Study Design : Economic Study

Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine